Medtronic (BSP:MDTC34) Other Current Payables: R$-0 Mil (As of Apr. 2026)


BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$212.73
GF Value R$247.33
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Other Current Payables?

Medtronic BSP:MDTC34 +1.02% 72 Other Current Payables is R$-0 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.33 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's Other Current Payables for the quarter that ended in Apr. 2026 was R$-0 Mil.

Medtronic's quarterly Other Current Payables stayed the same from Oct. 2025 (R$0 Mil) to Jan. 2026 (R$0 Mil) but then declined from Jan. 2026 (R$0 Mil) to Apr. 2026 (R$-0 Mil).

Medtronic's annual Other Current Payables declined from Apr. 2024 (R$0 Mil) to Apr. 2025 (R$0 Mil) and declined from Apr. 2025 (R$0 Mil) to Apr. 2026 (R$-0 Mil).

Medtronic Other Current Payables Related Terms

Medtronic Other Current Payables Historical Data

* Premium members only.

The historical data trend for Medtronic's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Other Current Payables Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 -0.00

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00
BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of R$-0 Mil mean?
Medtronic (BSP:MDTC34) has a Other Current Payables of R$-0 Mil as of Apr. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medtronic and its competitors.
Is Medtronic's Other Current Payables too high?
Medtronic's current Other Current Payables is R$-0 Mil. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Other Current Payables compare to SYK and BSX?
Medtronic's Other Current Payables of R$-0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medtronic and its competitors. Medtronic's current Other Current Payables is R$-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.33, compared to a current price of R$212.73 — trading 14% below its estimated fair value. The current Other Current Payables is R$-0 Mil. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Other Current Payables is R$-0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$212.73 is trading 14% below its estimated GF Value™ of R$247.33. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Other Current Payables: R$-0 Mil
  • GF Value™: R$247.33 vs. price of R$212.73 (14% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$212.73
Price
R$247.33
GF Value